Skip to main content
Premium Trial:

Request an Annual Quote

Terrapin Promotes Chemoinformatics Staff


SAN FRANCISCO--The privately held Terrapin Technologies pharmaceutical discovery company made several appointments and promotions that it said reflect progress made in applying Terrapin's proprietary chemoinformatics technology. Hugo Villar was promoted to vice-president, discovery technologies, where he will focus on expanding Terrapin's drug discovery platform; Edgardo Laborde, who established internal combinatorial chemistry capabilities since joining Terrapin in 1997 from Ariad Pharmaceuticals, was promoted to associate director, combinatorial chemistry; Steven Schow, most recently director of chemistry at CV Therapeutics, joined the company as senior director, medicinal chemistry; and Robert Lum, formerly of Arris Pharmaceuticals, will join the company as associate director, medicinal chemistry.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.